Date of announcement 2023/11/20
Time of announcement 18:12:36
Date of events 2023/11/20
To which item it meets paragraph 31

1.Date of the board of directors resolution:2023/11/20
2.Name and title of the managerial officer with permission to engage in
competitive conduct:Chun-Huei Ho /President
3.Items of competitive conduct in which the officer is permitted to engage:
T-E Pharma Holding/Director
4.Period of permission to engage in the competitive conduct:
During tenure of managerial officer.
5.Circumstances of the resolution (please describe the results of voting in
accordance with Article 32 of the Company Act):
Approved by the board of directors without the attendance of the
interested directors.
6.If the permitted competitive conduct belongs to the operator of a mainland
China area enterprise, the name and title of the managerial officer
(if it is not the operator of a mainland China area enterprise, please enter
“N/A” below):N/A
7.Company name of the mainland China area enterprise and the officer's
position in the enterprise:N/A
8.Address of the mainland China area enterprise:N/A
9.Operations of the mainland China area enterprise:N/A
10.Impact on the company's finance and business:None
11.If the managerial officer has invested in the mainland China area
enterprise, the monetary amount of the investment and the officer's
shareholding ratio:N/A
12.Any other matters that need to be specified:None